Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
cancer
2
×
amgen
battlefield
boston blog main
boston top stories
cancer drugs
clinical trials
cobimetinib
deals
disease
disrupt sf 2017
events
health
investing
ipo
life sciences
medicine
national blog main
national top stories
revolution medicines
roche
san francisco
san francisco blog main
san francisco top stories
sanofi
startups
tc
the column group
third rock ventures
university of illinois
venture capital
warp drive bio
What
cancer
despite
2
×
available
consequence
critical
day
determining
dozens
drug
family
great
guesswork
hardest
having
hit
hottest
hunters
important
ipo
late
matters
medicines
miscalculate
ourotech
path
prioritize
processes
proteins
pursuing
ras
read
reels
research
revolution
right
spent
stage
taking
targets
that’s
Language
unset
Current search:
despite
×
cancer
×
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@techcrunch.com
6 years ago
Ourotech is taking the guesswork out of cancer treatment